Clinical Trial Update: A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults [Phase 4]

View source ↗

Summary

Phase 4 randomized pilot study evaluating safety and tolerability of lorcaserin with two doses of immediate-release phentermine-HCl versus lorcaserin alone in o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Lorcaserin (lorcaserin)
• Phentermine-HCl (immediate-release) (phentermine hydrochloride)

Snippet

Sponsor: Eisai Inc. | Conditions: Chronic Weight Management | Phase 4 | Status: COMPLETED | Results posted: 2019-09-30